Brief: Caladrius Biosciences And Cend Therapeutics Announce Publication Of Pancreatic Cancer Trial Data In The Lancet Gastroenterology And Hepatology
06/07/2022 13:48
July 6 (Reuters) - Caladrius Biosciences Inc CLBS.O :
* CALADRIUS BIOSCIENCES AND CEND THERAPEUTICS ANNOUNCE
PUBLICATION
OF PANCREATIC CANCER TRIAL DATA IN THE LANCET GASTROENTEROLOGY
AND HEPATOLOGY
Source text for Eikon: ID:nGNX2S2NSt
Further company coverage: CLBS.O
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Lisata Therapeutics Announces New Method Of Use Patent Granted For Certepetide In The Treatment Of Pancreatic Cancer And Other Solid Tumors
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE -Expeditors International, Waters, Ameresco